Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$482M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$460M |
| 3 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$294M |
| 4 |
Tesla
TSLA
|
+$276M |
| 5 |
Caterpillar
CAT
|
+$247M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.79B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.01B |
| 3 |
Lowe's Companies
LOW
|
+$663M |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$404M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.68% |
| 2 | Healthcare | 6.62% |
| 3 | Financials | 5.53% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$771M
| $520K | ﹤0.01% |
15,564
| – | – |
|
3077
Collegium Pharmaceutical
COLL
$1.13B
| $518K | ﹤0.01% |
22,338
-6,313
| -22% | -$127K |
|
3078
MarineMax
HZO
$766M
| $518K | ﹤0.01% |
16,588
+3,235
| +24% | +$102K |
|
3079
RXO
RXO
$3.44B
| $516K | ﹤0.01% |
+30,020
| New | +$533K |
|
3080
Greif
GEF
$4.88B
| $514K | ﹤0.01% |
7,672
-3,898
| -34% | -$263K |
|
3081
Voyager Therapeutics
VYGR
$185M
| $513K | ﹤0.01% |
84,033
+80,749
| +2,459% | +$459K |
|
3082
Arqit Quantum
ARQQ
$306M
| $511K | ﹤0.01% |
5,667
+114
| +2% | +$16.7K |
|
3083
John B. Sanfilippo & Son
JBSS
$952M
| $511K | ﹤0.01% |
6,279
+1,099
| +21% | +$89.5K |
|
|
UBA
3084
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $511K | ﹤0.01% |
26,942
+3,575
| +15% | +$65.3K |
|
3085
TTEC Holdings
TTEC
$120M
| $510K | ﹤0.01% |
11,551
-663
| -5% | -$29.8K |
|
|
HMA
3086
DELISTED
Heartland Media Acquisition Corp.
HMA
| $509K | ﹤0.01% |
50,000
| – | – |
|
|
NNDM
3087
Nano Dimension
NNDM
$326M
| $507K | ﹤0.01% |
220,555
+29,350
| +15% | +$71.4K |
|
3088
PROG Holdings
PRG
$1.71B
| $507K | ﹤0.01% |
30,027
+5,864
| +24% | +$100K |
|
3089
Scansource
SCSC
$1.14B
| $506K | ﹤0.01% |
17,316
+1,073
| +7% | +$31.8K |
|
3090
Invesco S&P MidCap Low Volatility ETF
XMLV
$752M
| $505K | ﹤0.01% |
9,449
-981
| -9% | -$51.6K |
|
3091
PUT
JD.com
JD
$44.3B
| $505K | ﹤0.01% |
9,000
| – | – |
|
3092
Willis Lease Finance
WLFC
$1.74B
| $504K | ﹤0.01% |
25,647
+24,417
| +1,985% | +$365K |
|
3093
WisdomTree International SmallCap Dividend Fund
DLS
$1.06B
| $504K | ﹤0.01% |
8,698
+338
| +4% | +$18.8K |
|
3094
Ichor Holdings
ICHR
$2.72B
| $504K | ﹤0.01% |
18,781
-616
| -3% | -$16.4K |
|
|
DOOR
3095
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $504K | ﹤0.01% |
6,247
-185
| -3% | -$13.7K |
|
3096
Grupo Aeroportuario del Sureste
ASR
$8.38B
| $503K | ﹤0.01% |
2,160
+174
| +9% | +$40.5K |
|
3097
Descartes Systems
DSGX
$6.4B
| $503K | ﹤0.01% |
7,221
-72
| -1% | -$4.92K |
|
3098
Estrella Immunopharma
ESLA
$33.2M
| $502K | ﹤0.01% |
48,825
-13,210
| -21% | -$134K |
|
|
HSKA
3099
DELISTED
Heska Corp
HSKA
| $502K | ﹤0.01% |
8,078
+1,810
| +29% | +$122K |
|
|
CBAY
3100
CALL
DELISTED
Cymabay Therapeutics
CBAY
| $502K | ﹤0.01% |
80,000
+35,000
| +78% | +$133K |
|
Similar funds
Citigroup's Q4 2022 Portfolio in Review
As of Q4 2022, Citigroup held 6,223 positions worth $126B, down 10% from $140B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Citigroup withdrew a net $21.4B in Q4 2022, closing 469 positions and reducing 2,674 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $404M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citigroup opened a new position in Invesco Dorsey Wright Consumer Staples Momentum ETF worth $21.5M.
- Citigroup's largest Q4 2022 buy was Invesco Dorsey Wright Consumer Staples Momentum ETF: 260,000 shares worth $21.5M.
- Citigroup added most to State Street Consumer Staples Select Sector SPDR ETF in Q4 2022, an estimated $482M increase.
- Citigroup's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.79B.
- Citigroup fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $404M.
- Citigroup's ten largest holdings make up 26% of its $126B portfolio in Q4 2022.
- Citigroup opened 309 new positions and closed 469 in Q4 2022.
- Citigroup's portfolio value fell 10% quarter-over-quarter to $126B.
Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.